PDF(1593 KB)
乌司他丁干预对脓毒症幼鼠血清肿瘤坏死因子-α、P-选择素和凝血酶抗凝血酶复合物水平的影响
刘赟, 吴星恒
中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (2) : 237-241.
PDF(1593 KB)
PDF(1593 KB)
乌司他丁干预对脓毒症幼鼠血清肿瘤坏死因子-α、P-选择素和凝血酶抗凝血酶复合物水平的影响
Effect of ulinastatin on serum levels of tumor necrosis factor-α, P-selectin, and thrombin-antithrombin complex in young rats with sepsis
目的 探讨使用乌司他丁 （UTI）作为早期干预药物对脓毒症幼鼠血清肿瘤坏死因子-α （TNF-α）、P-选择素、凝血酶抗凝血酶复合物 （TAT）水平的影响及意义。方法 将120只4周龄雄性大鼠随机分为正常对照组、假手术组、脓毒症组、低剂量UTI干预组 （50000U/kg）和高剂量UTI干预组 （200000U/kg），每组24只。采用改良的盲肠结扎穿孔法制作脓毒症大鼠模型，低剂量和高剂量UTI干预组在建模后分别尾静脉注射UTI。ELISA法测定6、12、24h时各组大鼠血清TNF-α、P-选择素、TAT水平。结果 脓毒症组大鼠血清TNF-α、TAT、P-选择素水平在6h时即出现显著升高，血清TNF-α、TAT水平至24h时仍呈持续升高状态 （P < 0.05）；P-选择素在12h时达到峰值，24h时出现回落 （P < 0.05）。UTI干预组中，P-选择素和TAT水平变化趋势和脓毒症组相同，TNF-α水平在6h出现明显的增高，但随时间延长逐渐降低，且变化幅度均显著小于脓毒症组 （P < 0.05）；高剂量组变化幅度显著小于低剂量组 （P < 0.05）。结论 UTI早期干预对脓毒症幼鼠模型的凝血功能有明显的改善，能抑制TNF-α、P-选择素、TAT的生成，且高剂量组较低剂量组作用更显著。
Objective To investigate the effect of ulinastatin (UTI) for early drug intervention on the serum levels of tumor necrosis factor-α (TNF-α), P-selectin, and thrombin-antithrombin complex (TAT) in young rats with sepsis. Methods A total of 120 male rats aged 4 weeks were randomly divided into normal control group, shamoperation group, sepsis group, low-dose UTI group (50 000 U/kg), and high-dose UTI group (200 000 U/kg), with 24 rats in each group. Modified cecal ligation and puncture was performed to establish a rat model of sepsis, and the rats in the low- and high-dose UTI groups were given caudal vein injection of UTI after model establishment. ELISA was used to measure the serum levels of TNF-α, P-selectin, and TAT at 6, 12, and 24 hours after model establishment. Results The sepsis group had significant increases in the serum levels of TNF-α, P-selectin, and TAT at 6 hours, and the serum levels of TNF-α and TAT continued to increase by 24 hours (P < 0.05); P-selectin reached the peak at 12 hours and decreased slightly at 24 hours (P < 0.05). The UTI groups had similar change patterns in the levels of P-selectin and TAT as the sepsis group. The UTI groups had significant increases in the level of TNF-α at 6 hours, but gradually decreased over time. The changes in serum levels of TNF-α, P-selectin, and TAT in the UTI groups were significantly smaller than in the sepsis group (P < 0.05). The high-dose UTI group had significantly smaller changes in serum levels of TNF-α, P-selectin, and TAT than the low-dose UTI group (P < 0.05). Conclusions Early intervention with UTI can significantly improve coagulation function and inhibit the production of TNF-α, P-selectin, and TAT in young rats with sepsis. High-dose UTI has a significantly greater effect than low-dose UTI.
乌司他丁 / 脓毒症 / 肿瘤坏死因子-α / P-选择素 / 凝血酶抗凝血酶复合物 / 大鼠
Ulinastatin / Sepsis / Tumor necrosis factor-α / P-selectin / Thrombin-antithrombin complex / Rats
[1] Fleischmann C,Scherag A,Adhikari NK,et al.Assessment of global incidence and mortality of hospital-treated sepsis.Current estimates and limitations[J].Am J Respir Crit Care Med,2016, 193(3):259-272.
[2] Singer M,Deutschman CS,Seymour CW,et al.The third international consensus definitions for sepsis and septic shock (sepsis-3)[J].JAMA,2016,315(8):801-810.
[3] Atal SS,Atal S.Ulinastatin-a newer potential therapeutic option for multiple organ dysfunction syndrome[J].J Basic Clin Physiol Pharmacol,2016,27(2):91-99.
[4] Uchida M,Abe T,Ono K.The effects of ulinastatin in multiple organ failure:a retrospective observational study in a single center ICU[J].Intensive Care Med Exp,2015,3(Suppl 1):A878.
[5] Wang FY,Fang B,Qiang XH,et al.The efficacy and immunomodulatory effects of ulinastatin and thymosin α1 for sepsis:a systematic review and Meta-analysis[J].Biomed Res Int,2016,2016:9508493.
[6] Zhang H,Kovacs-Nolan J,Kodera T,et al.γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor[J].Biochim Biophys Acta,2015,1852(5):792-804.
[7] Newcomb D,Bolgos G,Green L,et al.Antibiotic treatment influences outcome in murine sepsis:mediators of increased morbidity[J].Shock,1998,10(2):110-117.
[8] Ruiz S,Vardon-Bounes F,Merlet-Dupuy V,et al.Sepsis modeling in mice:ligation length is a major severity factor in cecal ligation and puncture[J].Intensive Care Med Exp,2016, 4(1):22.
[9] Vincent JL,Opal SM,Marshall JC,et al.Sepsis definitions:time for change[J].Lancet,2013,381(9868):774-775.
[10] Shubin NJ,Monaghan SF,Ayala A.Anti-inflammatory mechanisms of sepsis[J].Contrib Microbiol,2011,17:108-124.
[11] Kutlar A,Embury SH.Cellular adhesion and the endothelium: P-selectin[J].Hematol Oncol Clin North Am,2014,28(2):323- 339.
[12] Han D,Shang W,Wang G,et al.Ulinastatin-and thymosin α1- based immunomodulatory strategy for sepsis:a meta-analysis[J]. Int Immunopharmacol,2015,29(2):377-382.
[13] Karnad DR,Bhadade R,Verma PK,et al.Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis:a multicenter randomized controlled study[J]. Intensive Care Med,2014,40(6):830-838.
[14] Guan L,Liu H,Fu P,et al.The protective effects of trypsin inhibitor on hepatic ischemia-reperfusion injury and liver graft survival[J].Oxid Med Cell Longev,2016,2016:1429835.
[15] Hao X,Cai G,Hu C.The effect of ulinastatin on sepsis in the rats of adhesion molecules and endothelial function[J].Intensive Care Med Exp,2015,3(Suppl 1):A617.
[16] Liu G,Li Q.Meta-analysis of xuebijing joint ulinastatin treating sepsis[J].Value Health,2014,17(7):A807.
[17] 袁远宏,肖政辉,张慧,等.连续血液净化对严重脓毒症患儿T细胞亚群的影响[J].中国当代儿科杂志,2014,16(2): 194-197.
